Pharma's Almanac TV
PA TV
Follow the Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Current Issue
Archive
Reports
Biologics Pricing Report
Oral Solid Dose Market Report
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
By The Numbers
Press Releases
2707 Articles Available
1
113
Can't find what you're looking for? Try our
advanced search
.
Rebranding
Immune Regulation Announces Rebranding to Revolo Biotherapeutics, Reflecting a Revolutionary Approach to Resetting the Immune System to Treat Autoimmune and Allergic Diseases
PR-M11-20-041
WuXi AppTec Completes Acquisition of OXGENE to Further Strengthen Cell and Gene Therapy Service Offerings for Global Customers
PR-M11-20-040
Patent
Patent on Improved Particle Size Testing Method Granted to Hovione will Impact Market
PR-M11-20-039
Arthritis Treatment
Nesos Announces Peer-Reviewed Validation Of Its First-of-its-Kind Wireless Earbud for the Treatment of Rheumatoid Arthritis
PR-M11-20-038
Expansion
Colliers Completes New Headquarters Search for Rapidly Growing Gene Therapy Firm Spirovant
PR-M11-20-037
Human Genome
Tecan’s First Virtual Genomics Symposium
PR-M11-20-036
Acquisition
Thermo Fisher Scientific Acquires Viral Vector Manufacturing Business from Novasep
PR-M11-20-035
Expansion
Cognate BioServices and its Gene Therapy Division Cobra Biologics Announce Major Expansion of Manufacturing Facilities in US and Europe
PR-M11-20-034
Screening Service
Hovione Launches ASD-HIPROS the Most Advanced Screening Service for Optimal Spray Dried Dispersions Formulation
PR-M11-20-033
Strategic Partnership
PharmaBlock Enters Strategic Partnership with Ascentage Pharma
PR-M11-20-032
COVID-19 Vaccine
HALIX Signs Agreement With AstraZeneca For Commercial Manufacture Of COVID-19 Vaccine
PR-M11-20-031
Strategic Collaboration
Bayer and Atara Biotherapeutics Enter Strategic Collaboration for Mesothelin-Targeted CAR T-cell Therapies for Solid Tumors
PR-M11-20-030
Sustainability
Vetter Continues to Implement its Long-Term Sustainability Strategy
PR-M11-20-029
FDA Approves First PSMA-Targeted PET Imaging Drug for Men with Prostate Cancer
PR-M11-20-028
FDA Approval
Blueprint Medicines Announces FDA Approval of GAVRETO™ (pralsetinib) for the Treatment of Patients with Advanced or Metastatic RET-Mutant and RET Fusion-Positive Thyroid Cancer
PR-M11-20-027
Vaccine
Cobra Biologics Signs Supply Agreement with AstraZeneca for Manufacture of COVID-19 Vaccine Candidate
PR-M11-20-026
FDA Authorization
Babson Diagnostics Receives FDA Emergency Use Authorization for its SARS-CoV-2 IgG Antibody Test
PR-M11-20-025
Mental Health
This Ancient Aztec Medicine Could Be a Gamechanger for Mental Health
PR-M11-20-024
Antibodies
Lilly's Neutralizing Antibody Bamlanivimab (LY-CoV555) Receives FDA Emergency Use Authorization for the Treatment of Recently Diagnosed COVID-19
PR-M11-20-023
FDA Authorization
Baricitinib Receives Emergency Use Authorization from the FDA for the Treatment of Hospitalized Patients with COVID-19
PR-M11-20-022
Microfluids
Enhancing Interferometry with Dolomite’s Mitos Dropix
PR-M11-20-024
COVID-19 Vaccine
Russia's Sputnik V COVID-19 Vaccine Is 91% Effective
PR-M11-20-023
Antibodies
Twist Bioscience Announces Positive Preclinical Data for SARS-CoV-2 Antibodies
PR-M11-20-022
Clinical Study
Iron Oxides Enhance Protection Against Skin Damage
PR-M11-20-021
1
113
»
